{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T12:19:23Z","timestamp":1794313163434,"version":"4.9.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01KD2206M"],"award-info":[{"award-number":["01KD2206M"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01KD2206M"],"award-info":[{"award-number":["01KD2206M"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","award":["70115995"],"award-info":[{"award-number":["70115995"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","award":["70115995"],"award-info":[{"award-number":["70115995"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","award":["70115995"],"award-info":[{"award-number":["70115995"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008967","name":"Philipps-Universit\u00e4t Marburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008967","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocr Pathol"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Mixed neuroendocrine\u2013nonneuroendocrine neoplasms (MiNEN) are usually highly aggressive tumors characterized by marked histological heterogeneity, most commonly represented by mixed adenocarcinoma and poorly differentiated neuroendocrine carcinoma (NEC). However, beyond morphological observations, the biological basis and implications of this heterogeneity remain incompletely understood. In this study, we combined component-specific next-generation sequencing and spatial transcriptomics to investigate three mixed adenocarcinoma-NEC cases from different anatomical sites (ileocecal, ovarian, gastric), tracing tumor progression from precursor lesions to invasive NEC. Genomic analyses revealed a shared trunk of driver mutations across all tumor compartments, confirming their clonal origin, while also uncovering additional compartment-specific alterations. Spatial transcriptomics, together with gene set enrichment analysis (GSEA), revealed distinct transcriptional profiles aligned with histologically annotated compartments (e.g., adenocarcinoma, NEC, precursor). In NECs, GSEA consistently showed downregulation of immune-related pathways and upregulation of proliferation-associated pathways compared to non-neuroendocrine tumor areas. Moreover, distinct transcriptomic subclusters were identified within morphologically homogeneous NEC regions in two of the three cases. These subclusters exhibited significant differences in immune regulation, proliferation signaling, and cell-cycle control, and were associated with divergent predicted chemotherapy-response signatures, suggesting clinically relevant implications for treatment sensitivity and resistance. In summary, our findings indicate that despite a shared clonal origin, MiNEN develop distinct genetic and transcriptomic features across tumor compartments. The inconsistent presence of transcriptomic subclusters within morphologically similar regions underscores the complexity of intratumoral heterogeneity in these aggressive neoplasms. By connecting morphological and molecular layers of tumor architecture, spatial profiling may aid in translating biological complexity into more targeted clinical strategies.<\/jats:p>","DOI":"10.1007\/s12022-025-09869-w","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T04:52:19Z","timestamp":1755665539000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Exploring\u00a0Intratumoral\u00a0Heterogeneity\u00a0in\u00a0Mixed Neuroendocrine-Nonneuroendocrine Neoplasms with Spatial Transcriptomics: Even More Diverse Than Anticipated"],"prefix":"10.1007","volume":"36","author":[{"given":"Annika","family":"Wei\u00df","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Teply-Szymanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Foersch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Jank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joscha","family":"Griger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Detlef K.","family":"Bartsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Denkert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moritz","family":"Jesinghaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"key":"9869_CR1","unstructured":"(2019) WHO Classification of Tumours: Digestive system tumours Fifth Edition. International Agency for Research on Cancer; 2019"},{"key":"9869_CR2","doi-asserted-by":"publisher","unstructured":"Alizadeh AA, Aranda V, Bardelli A, Blanpain C, Bock C, Borowski C, Caldas C, Califano A, Doherty M, Elsner M, Esteller M, Fitzgerald R, Korbel JO, Lichter P, Mason CE, Navin N, Pe'er D, Polyak K, Roberts CW, Siu L, Snyder A, Stower H, Swanton C, Verhaak RG, Zenklusen JC, Zuber J, Zucman-Rossi J (2015) Toward understanding and exploiting tumor heterogeneity Nat Med 21:846-853.\u00a0https:\/\/doi.org\/10.1038\/nm.3915","DOI":"10.1038\/nm.3915"},{"key":"9869_CR3","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1159\/000469664","volume":"85","author":"FT Bosman","year":"2018","unstructured":"Bosman FT (2018) Tumor Heterogeneity: Will It Change What Pathologists Do. Pathobiology 85:18\u201322. https:\/\/doi.org\/10.1159\/000469664","journal-title":"Pathobiology"},{"key":"9869_CR4","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.molonc.2014.06.005","volume":"8","author":"RA Burrell","year":"2014","unstructured":"Burrell RA, Swanton C (2014) Tumour heterogeneity and the evolution of polyclonal drug resistance. Mol Oncol 8:1095\u20131111. https:\/\/doi.org\/10.1016\/j.molonc.2014.06.005","journal-title":"Mol Oncol"},{"key":"9869_CR5","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/s41575-024-00934-z","volume":"21","author":"A Canellas-Socias","year":"2024","unstructured":"Canellas-Socias A, Sancho E, Batlle E (2024) Mechanisms of metastatic colorectal cancer. Nat Rev Gastroenterol Hepatol 21:609\u2013625. https:\/\/doi.org\/10.1038\/s41575-024-00934-z","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"9869_CR6","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/s41571-024-00926-7","volume":"21","author":"J Chen","year":"2024","unstructured":"Chen J, Larsson L, Swarbrick A, Lundeberg J (2024) Spatial landscapes of cancers: insights and opportunities. Nat Rev Clin Oncol 21:660\u2013674. https:\/\/doi.org\/10.1038\/s41571-024-00926-7","journal-title":"Nat Rev Clin Oncol"},{"key":"9869_CR7","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","volume":"15","author":"I Dagogo-Jack","year":"2018","unstructured":"Dagogo-Jack I, Shaw AT (2018) Tumour heterogeneity and resistance to cancer therapies. Nat Rev Clin Oncol 15:81\u201394. https:\/\/doi.org\/10.1038\/nrclinonc.2017.166","journal-title":"Nat Rev Clin Oncol"},{"key":"9869_CR8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s42255-023-00963-z","volume":"6","author":"M Demicco","year":"2024","unstructured":"Demicco M, Liu XZ, Leithner K, Fendt SM (2024) Metabolic heterogeneity in cancer Nat Metab 6:18\u201338. https:\/\/doi.org\/10.1038\/s42255-023-00963-z","journal-title":"Metabolic heterogeneity in cancer Nat Metab"},{"key":"9869_CR9","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1053\/j.gastro.2014.11.024","volume":"148","author":"ER Fearon","year":"2015","unstructured":"Fearon ER, Carethers JM (2015) Molecular subtyping of colorectal cancer: time to explore both intertumoral and intratumoral heterogeneity to evaluate patient outcome. Gastroenterology 148:10\u201313. https:\/\/doi.org\/10.1053\/j.gastro.2014.11.024","journal-title":"Gastroenterology"},{"key":"9869_CR10","doi-asserted-by":"publisher","first-page":"5991","DOI":"10.3748\/wjg.v25.i39.5991","volume":"25","author":"M Frizziero","year":"2019","unstructured":"Frizziero M, Wang X, Chakrabarty B, Childs A, Luong TV, Walter T, Khan MS, Morgan M, Christian A, Elshafie M, Shah T, Minicozzi A, Mansoor W, Meyer T, Lamarca A, Hubner RA, Valle JW, McNamara MG (2019) Retrospective study on mixed neuroendocrine non-neuroendocrine neoplasms from five European centres. World J Gastroenterol 25:5991\u20136005. https:\/\/doi.org\/10.3748\/wjg.v25.i39.5991","journal-title":"World J Gastroenterol"},{"key":"9869_CR11","doi-asserted-by":"publisher","unstructured":"Griger J, Widholz SA, Jesinghaus M, de Andrade Kratzig N, Lange S, Engleitner T, Montero JJ, Zhigalova E, Ollinger R, Suresh V, Winkler W, Lier S, Baranov O, Trozzo R, Ben Khaled N, Chakraborty S, Yu J, Konukiewitz B, Steiger K, Pfarr N, Rajput A, Sailer D, Keller G, Schirmacher P, Rocken C, Fagerstedt KW, Mayerle J, Schmidt-Supprian M, Schneider G, Weichert W, Calado DP, Sommermann T, Kloppel G, Rajewsky K, Saur D, Rad R (2023) An integrated cellular and molecular model of gastric neuroendocrine cancer evolution highlights therapeutic targets. Cancer Cell 41: 1327\u20131344\u00a0e1310. https:\/\/doi.org\/10.1016\/j.ccell.2023.06.001","DOI":"10.1016\/j.ccell.2023.06.001"},{"key":"9869_CR12","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/modpathol.2016.220","volume":"30","author":"M Jesinghaus","year":"2017","unstructured":"Jesinghaus M, Konukiewitz B, Keller G, Kloor M, Steiger K, Reiche M, Penzel R, Endris V, Arsenic R, Hermann G, Stenzinger A, Weichert W, Pfarr N, Kloppel G (2017) Colorectal mixed adenoneuroendocrine carcinomas and neuroendocrine carcinomas are genetically closely related to colorectal adenocarcinomas Mod Pathol 30:610-619. https:\/\/doi.org\/10.1038\/modpathol.2016.220","journal-title":"Mod Pathol"},{"key":"9869_CR13","doi-asserted-by":"publisher","unstructured":"Jesinghaus M, Schmitt M, Lang C, Reiser M, Scheiter A, Konukiewitz B, Steiger K, Silva M, Tschurtschenthaler M, Lange S, Foersch S, Becker KF, Saur D, Friess H, Halfter K, Engel J, Boxberg M, Pfarr N, Wilhelm D, Weichert W (2021) Morphology Matters: A Critical Reappraisal of the Clinical Relevance of Morphologic Criteria From the 2019 WHO Classification in a Large Colorectal Cancer Cohort Comprising 1004 Cases Am J Surg Pathol 45:969\u2013978.\u00a0https:\/\/doi.org\/10.1097\/pas.0000000000001692","DOI":"10.1097\/pas.0000000000001692"},{"key":"9869_CR14","doi-asserted-by":"publisher","unstructured":"Ji M, Fan D, Yuan Y, Wang J, Feng X, Yang W, Dang X, Xu Y, Wang J (2025) Investigation into the Spatial Heterogeneity of Lung Composite Large-Cell Neuroendocrine Carcinoma Spatial Transcriptomic Analysis of Combined Large-Cell Neuroendocrine Carcinoma Cancer Biother Radiopharm.\u00a0https:\/\/doi.org\/10.1089\/cbr.2025.0043","DOI":"10.1089\/cbr.2025.0043"},{"key":"9869_CR15","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/path.5556","volume":"253","author":"J Koh","year":"2021","unstructured":"Koh J, Nam SK, Kwak Y, Kim G, Kim KK, Lee BC, Ahn SH, Park DJ, Kim HH, Park KU, Kim WH, Lee HS (2021) Comprehensive genetic features of gastric mixed adenoneuroendocrine carcinomas and pure neuroendocrine carcinomas. J Pathol 253:94\u2013105. https:\/\/doi.org\/10.1002\/path.5556","journal-title":"J Pathol"},{"key":"9869_CR16","doi-asserted-by":"publisher","unstructured":"Konukiewitz B, Jesinghaus M, Steiger K, Schlitter AM, Kasajima A, Sipos B, Zamboni G, Weichert W, Pfarr N, Kloppel G (2018) Pancreatic neuroendocrine carcinomas reveal a closer relationship to ductal adenocarcinomas than to neuroendocrine tumors G3 Hum Pathol 77:70\u201379.\u00a0https:\/\/doi.org\/10.1016\/j.humpath.2018.03.018","DOI":"10.1016\/j.humpath.2018.03.018"},{"key":"9869_CR17","doi-asserted-by":"publisher","unstructured":"Konukiewitz B, Kasajima A, Schmitt M, Schwamborn K, Groll T, Schicktanz F, Delbridge C, Schutze LM, Wilhelm D, Lang C, Lange S, Foersch S, Jank P, Steiger K, Werder AV, Denkert C, Weichert W, Kloppel G, Jesinghaus M (2021) Neuroendocrine Differentiation in Conventional Colorectal Adenocarcinomas: Incidental Finding or Prognostic Biomarker? Cancers (Basel) 13.\u00a0https:\/\/doi.org\/10.3390\/cancers13205111","DOI":"10.3390\/cancers13205111"},{"key":"9869_CR18","doi-asserted-by":"publisher","unstructured":"Kraemer M, Zander T, Alakus H, Buettner R, Lyu SI, Simon AG, Schroeder W, Bruns CJ, Quaas A (2024) Fetal gut cell-like differentiation in esophageal adenocarcinoma defines a rare tumor subtype with therapeutically relevant claudin-6 positivity and SWI\/SNF gene alteration Sci Rep 14:13474.\u00a0https:\/\/doi.org\/10.1038\/s41598-024-64116-2","DOI":"10.1038\/s41598-024-64116-2"},{"key":"9869_CR19","doi-asserted-by":"publisher","unstructured":"Kwak Y, Nam SK, Park Y, Suh YS, Ahn SH, Kong SH, Park DJ, Lee HJ, Kim HH, Yang HK, Lee HS (2024) Distinctive Phenotypic and Microenvironmental Characteristics of Neuroendocrine Carcinoma and Adenocarcinoma Components in Gastric Mixed Adenoneuroendocrine Carcinoma. Mod Pathol 37. https:\/\/doi.org\/10.1016\/j.modpat.2024.100568","DOI":"10.1016\/j.modpat.2024.100568"},{"key":"9869_CR20","doi-asserted-by":"publisher","unstructured":"La Rosa S, Marando A, Sessa F, Capella C (2012) Mixed Adenoneuroendocrine Carcinomas (MANECs) of the Gastrointestinal Tract: An Update Cancers (Basel) 4:11\u201330. https:\/\/doi.org\/10.3390\/cancers4010011","DOI":"10.3390\/cancers4010011"},{"key":"9869_CR21","doi-asserted-by":"publisher","unstructured":"Litmeyer AS, Konukiewitz B, Kasajima A, Foersch S, Schicktanz F, Schmitt M, Kellers F, Grass A, Jank P, Lehman B, Gress TM, Rinke A, Bartsch DK, Denkert C, Weichert W, Kloppel G, Jesinghaus M (2023) High expression of insulinoma-associated protein 1 (INSM1) distinguishes colorectal mixed and pure neuroendocrine carcinomas from conventional adenocarcinomas with diffuse expression of synaptophysin J Pathol Clin Res 9:498\u2013509.\u00a0https:\/\/doi.org\/10.1002\/cjp2.339","DOI":"10.1002\/cjp2.339"},{"key":"9869_CR22","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41586-021-03634-9","volume":"596","author":"A Rao","year":"2021","unstructured":"Rao A, Barkley D, Franca GS, Yanai I (2021) Exploring tissue architecture using spatial transcriptomics Nature 596:211\u2013220. https:\/\/doi.org\/10.1038\/s41586-021-03634-9","journal-title":"Exploring tissue architecture using spatial transcriptomics Nature"},{"key":"9869_CR23","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1002\/path.6158","volume":"260","author":"S Thakur","year":"2023","unstructured":"Thakur S, Haider S, Natrajan R (2023) Implications of tumour heterogeneity on cancer evolution and therapy resistance: lessons from breast cancer. J Pathol 260:621\u2013636. https:\/\/doi.org\/10.1002\/path.6158","journal-title":"J Pathol"},{"key":"9869_CR24","doi-asserted-by":"publisher","unstructured":"Uccella S, La Rosa S (2020) Looking into digestive mixed neuroendocrine - nonneuroendocrine neoplasms: subtypes, prognosis, and predictive factors Histopathology 77:700\u2013717.\u00a0https:\/\/doi.org\/10.1111\/his.14178","DOI":"10.1111\/his.14178"},{"key":"9869_CR25","doi-asserted-by":"publisher","unstructured":"Walter T, Lievre A, Coriat R, Malka D, Elhajbi F, Di Fiore F, Hentic O, Smith D, Hautefeuille V, Roquin G, Perrier M, Dahan L, Granger V, Sobhani I, Mineur L, Niccoli P, Assenat E, Scoazec JY, Le Malicot K, Lepage C, Lombard-Bohas C (2023) Bevacizumab plus FOLFIRI after failure of platinum-etoposide first-line chemotherapy in patients with advanced neuroendocrine carcinoma (PRODIGE 41-BEVANEC): a randomised, multicentre, non-comparative, open-label, phase 2 trial Lancet Oncol 24:297\u2013306.\u00a0https:\/\/doi.org\/10.1016\/s1470-2045(23)00001-3","DOI":"10.1016\/s1470-2045(23)00001-3"},{"key":"9869_CR26","doi-asserted-by":"publisher","unstructured":"Weaver JMJ, Hubner RA, Valle JW, McNamara MG (2023) Selection of Chemotherapy in Advanced Poorly Differentiated Extra-Pulmonary Neuroendocrine Carcinoma Cancers (Basel) 15.\u00a0https:\/\/doi.org\/10.3390\/cancers15204951","DOI":"10.3390\/cancers15204951"},{"key":"9869_CR27","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/modpathol.2016.150","volume":"30","author":"C Woischke","year":"2017","unstructured":"Woischke C, Schaaf CW, Yang HM, Vieth M, Veits L, Geddert H, Markl B, Stommer P, Schaeffer DF, Frolich M, Blum H, Vosberg S, Greif PA, Jung A, Kirchner T, Horst D (2017) In-depth mutational analyses of colorectal neuroendocrine carcinomas with adenoma or adenocarcinoma components. Mod Pathol 30:95\u2013103. https:\/\/doi.org\/10.1038\/modpathol.2016.150","journal-title":"Mod Pathol"},{"key":"9869_CR28","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1111\/cas.12473","volume":"105","author":"T Yamaguchi","year":"2014","unstructured":"Yamaguchi T, Machida N, Morizane C, Kasuga A, Takahashi H, Sudo K, Nishina T, Tobimatsu K, Ishido K, Furuse J, Boku N, Okusaka T (2014) Multicenter retrospective analysis of systemic chemotherapy for advanced neuroendocrine carcinoma of the digestive system. Cancer Sci 105:1176\u20131181. https:\/\/doi.org\/10.1111\/cas.12473","journal-title":"Cancer Sci"},{"key":"9869_CR29","doi-asserted-by":"publisher","unstructured":"Yoo M, Shin J, Kim J, Ryall KA, Lee K, Lee S, Jeon M, Kang J, Tan AC (2015) DSigDB: drug signatures database for gene set analysis Bioinformatics 31:3069\u20133071.\u00a0https:\/\/doi.org\/10.1093\/bioinformatics\/btv313","DOI":"10.1093\/bioinformatics\/btv313"}],"container-title":["Endocrine Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-025-09869-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12022-025-09869-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-025-09869-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T08:25:46Z","timestamp":1767860746000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12022-025-09869-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["9869"],"URL":"https:\/\/doi.org\/10.1007\/s12022-025-09869-w","relation":{},"ISSN":["1046-3976","1559-0097"],"issn-type":[{"value":"1046-3976","type":"print"},{"value":"1559-0097","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,20]]},"assertion":[{"value":"2 July 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our study was approved by the local ethics committees of the University Hospital Marburg (reference number: AZ 206\/10 and AZ 43\/21).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"During the preparation of this work, the authors used ChatGPT (OpenAI, Ireland Ltd, Dublin, Ireland) for spell checking. After using this tool\/service, the authors reviewed and edited the content as needed and take full responsibility for the content of the publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of Generative AI and AI-Assisted Technologies in the Writing Process"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"29"}}